Skip to main content
Clinical Trials/NCT02781935
NCT02781935
Completed
Not Applicable

Diffusion-Weighted Magnetic Resonance Imaging Assessment of Liver Metastasis to Improve Surgical Planning

European Organisation for Research and Treatment of Cancer - EORTC21 sites in 5 countries233 target enrollmentNovember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Enrollment
233
Locations
21
Primary Endpoint
Negative Predictive Value (NPV) of the diagnostic imaging (DW-MRI)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The DREAM study will assess the diagnostic accuracy of diffusion-weighted MRI in combination with other imaging modalities (multiparametric MRI and CT Scan) in determining the true status of disappearing liver metastasis (DLM) detected after conversion systemic therapy for unresectable or borderline resectable colorectal liver metastasis (CRLM).

Detailed Description

The advancements of systemic and local therapies for complex CRLM have led to the increased incidence of DLMs. It is hypothesized that DW-MRI imaging could distinguish between a metastasis not completely sterilized by conversion therapy and a sterilized scar (non-viable tumor). If this can be demonstrated, the use of DW-MRI could make a significant impact on the surgical decision making process by providing surgeons a more reliable guide to decide whether to leave behind or to resect/ablate a site of DLM. Most importantly, this surgical choice can also have a significant impact on patient outcomes as it may impact the risk of local recurrence and the need for re-operation.The possibility of improving surgical management of complex CRLM is foreseen if the benefit of observing or resecting small residual metastases and DLMs is clarified through a multi-center and international prospective study.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
September 27, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Contraindications to any contrast agents for CT and MRI or MRI procedure
  • Significant comorbidity that will preclude either conversion therapy or surgery

Outcomes

Primary Outcomes

Negative Predictive Value (NPV) of the diagnostic imaging (DW-MRI)

Time Frame: 2 years after surgery

Secondary Outcomes

  • Correlation between different types of morphologic and ADC changes and TRG to the type of conversion therapy(2 years after the surgery)
  • NPV of diagnostic imaging among the group of resected confirmed DLMs(2 years after the surgery)
  • NPV of DW-MRI in the group of cDLMs diagnosed by central imaging review(2 years after the surgery)
  • Correlation between findings on DW-MRI to histopathology, recurrence rate, complication rates, PFS and OS(2 years after initial surgery)
  • NPV of diagnostic imaging in the group of confirmed DLMs that were left in place(2 years after ther surgery)
  • Long term outcomes of patients who underwent surgery in terms of: - recurrence rates for 2 years after surgery - progression free survival for 2 years after surgery - overall survival for 2 years after surgery(2 years after initial surgery)

Study Sites (21)

Loading locations...

Similar Trials